Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fractional analysis of bronchoalveolar lavage fluid cytology in cystic fibrosis patients with normal lung function. Bronchoalveolar lavage for the evaluation of anti-inflammatory treatment (BEAT) study group.
Ratjen F, Rietschel E, Griese M, Ballmann M, Kleinau I, Döring G, Reinhardt D, Paul K. Ratjen F, et al. Among authors: doring g. Eur Respir J. 2000 Jan;15(1):141-5. doi: 10.1183/09031936.00.15114100. Eur Respir J. 2000. PMID: 10678636 Free article.
Effect of treatment with dornase alpha on airway inflammation in patients with cystic fibrosis.
Paul K, Rietschel E, Ballmann M, Griese M, Worlitzsch D, Shute J, Chen C, Schink T, Döring G, van Koningsbruggen S, Wahn U, Ratjen F; Bronchoalveolar Lavage for the Evaluation of Antiinflammatory Treatment Study Group. Paul K, et al. Among authors: doring g. Am J Respir Crit Care Med. 2004 Mar 15;169(6):719-25. doi: 10.1164/rccm.200307-959OC. Epub 2003 Dec 18. Am J Respir Crit Care Med. 2004. PMID: 14684561 Clinical Trial.
Cystic fibrosis.
Ratjen F, Döring G. Ratjen F, et al. Among authors: doring g. Lancet. 2003 Feb 22;361(9358):681-9. doi: 10.1016/S0140-6736(03)12567-6. Lancet. 2003. PMID: 12606185 Review.
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.
Konstan MW, Döring G, Heltshe SL, Lands LC, Hilliard KA, Koker P, Bhattacharya S, Staab A, Hamilton A; Investigators and Coordinators of BI Trial 543.45. Konstan MW, et al. Among authors: doring g. J Cyst Fibros. 2014 Mar;13(2):148-55. doi: 10.1016/j.jcf.2013.12.009. Epub 2014 Jan 17. J Cyst Fibros. 2014. PMID: 24440167 Free PMC article. Clinical Trial.
Expression and regulation of interferon-related development regulator-1 in cystic fibrosis neutrophils.
Hector A, Kormann M, Kammermeier J, Burdi S, Marcos V, Rieber N, Mays L, Illig T, Klopp N, Falkenstein F, Kappler M, Riethmueller J, Graepler-Mainka U, Stern M, Eickmeier O, Serve F, Zielen S, Döring G, Griese M, Hartl D. Hector A, et al. Among authors: doring g. Am J Respir Cell Mol Biol. 2013 Jan;48(1):71-7. doi: 10.1165/rcmb.2012-0061OC. Epub 2012 Oct 4. Am J Respir Cell Mol Biol. 2013. PMID: 23043087
Serology as a diagnostic tool for predicting initialPseudomonas aeruginosa acquisition in children with cystic fibrosis.
Daines C, VanDeVanter D, Khan U, Emerson J, Heltshe S, McNamara S, Anstead M, Langkamp M, Doring G, Ratjen F, Ramsey B, Gibson RL, Morgan W, Rosenfeld M; EPIC Investigators. Daines C, et al. Among authors: doring g. J Cyst Fibros. 2014 Sep;13(5):542-9. doi: 10.1016/j.jcf.2014.06.005. Epub 2014 Jul 11. J Cyst Fibros. 2014. PMID: 25027419 Free article.
358 results